Longitudinal trends and cross-sectional analysis of English national hospital antibacterial use over 5 years (2008-13): Working towards hospital prescribing quality measures

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 1, 2015, Pages 279-285

  Cooke, Jonathan ^a,b   Stephens, Peter ^c   Ashiru Oredope, Diane ^d   Charani, Esmita ^a   Dryden, Mathew ^e   Fry, Carole ^f   Hand, Kieran ^g   Holmes, Alison ^a   Howard, Philip ^h   Johnson, Alan P ^d   Livermore, David M ^d,i   Mansell, Paula ^j   Mcnulty, Cliodna A M ^k   Wellsteed, Sally ^f   Hopkins, Susan ^d,l   Sharland, Mike ^m  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c IQVIA   (United States)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^f Department of Health   (United Kingdom)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

ⁱ UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^j CARE QUALITY COMMISSION   (United Kingdom)

^k GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^l ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^m ST GEORGE S HOSPITAL   (United Kingdom)

more..

Author keywords

Antibiotics; Antimicrobial stewardship; Hospital usage

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; FLUCLOXACILLIN; IMIDAZOLE DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM DERIVATIVE;

ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DATA BASE; DRUG USE; HEALTH CARE INDUSTRY; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LONGITUDINAL STUDY; NATIONAL HEALTH SERVICE; PRESCRIPTION; QUALITY CONTROL; UNITED KINGDOM; DRUG UTILIZATION; HEALTH CARE POLICY; HEALTH SERVICES RESEARCH; HOSPITAL; STANDARDS; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; ENGLAND; HEALTH POLICY; HEALTH SERVICES RESEARCH; HOSPITALS; LONGITUDINAL STUDIES; PRESCRIPTIONS; QUALITY CONTROL;

EID: 84928334050     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku328     Document Type: Article

References (40)

1. WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR). Antimicrobial Resistance: Global Report on Surveillance 2014. http://www.sosbexiga.com/pdf/1_Maio_2014.pdf.
2. Howell L. Global Risks 2013, Eighth Edition. An Initiative of the Risk Response Network. World Economic Forum, 2013. http://www3.weforum.org/docs/WEF_GlobalRisks_Report_2013.pdf.
3. Baiden F, Owusu-Agyei S, Webster J et al. The need for new antibiotics. Lancet 2010; 375: 637-8.
4. Wellington EMH, Boxall ABA, Cross P et al. The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria. Lancet Infect Dis 2013; 13: 155-65.
5. Isaacs D, Andresen D. Combating antibiotic resistance: the war on error. Arch Dis Child 2013; 98: 90-1.
6. Department of Health Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI). Antimicrobial Stewardship: 'Start Smart-Then Focus'. Guidance for Antimicrobial Stewardship in Hospitals (England). London: Department of Health, 2011. https://www. gov.uk/government/uploads/system/uploads/attachment_data/file/215309/dh_131185.pdf.
7. Department of Health Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI). Guidance for Antimicrobial Stewardship in Hospitals (England). Appendix 1-Resource Materials: Examples of Audit Tools, Review Stickers and Drug Charts. London: Department of Health, 2011. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/215309/dh_131185.pdf.
8. Ashiru-Oredope D, Sharland M, Charani E et al. on behalf of ARHAI Antimicrobial Stewardship Group. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart-Then Focus. J Antimicrob Chemother 2012; 67 Suppl 1: i51-63.
9. van de Sande-Bruinsma N, Grundmann H, Verloo D et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008; 14: 1722-30.
10. Goossens H. Expert-proposed European strategies to monitor and control infection, antibiotic use, and resistance in health-care facilities. Lancet Infect Dis 2011; 11: 338-40.
11. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2014. http://www.whocc.no/atc_ddd_index/.
12. ECDC. Point Prevalence Survey of Healthcare-associated Infections and Antimicrobial Use in European Acute Care Hospitals. Stockholm, 2013. http://www.ecdc.europa.eu/en/publications/publications/healthcare-associatedinfections-antimicrobial-use-pps.pdf.
13. Hospital Episode Statistics, Admitted Patient Care, England 2012-13. 2013. http://www.hscic.gov.uk/catalogue/PUB12566.
14. Richards M. Extent and Causes of International Variations in Drug Usage. A Report for the Secretary of State for Health. London: Crown, 2010. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216249/dh_117977.pdf.
15. Department of Health and HPA. Clostridium difficile Infection: How to Deal with the Problem. London: Department of Health, 2008. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1232006607827.
16. HPA. Summary Points on Clostridium difficile Infection (CDI). London, 2012. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1278944283388.
17. Livermore DM, Hope R, Reynolds R et al. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother 2013; 68: 2667-74.
18. Nordmann P, Naas T, Poirel L. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 1791-8.
19. Ibrahim OM, Polk RE. Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti Infect Ther 2012; 10: 445-57.
20. Dumartin C, L'Heriteau F, Pefau M et al. Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. J Antimicrob Chemother 2010; 65: 2028-36.
21. WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR). Critically Important Antimicrobials for Human Medicine. WHO, 2011.
22. Council of the European Union. Council Conclusions on the Impact of Antimicrobial Resistance in the Human Health Sector and in the Veterinary Sector-A 'One Health' Perspective. Luxembourg, 2012. http://www.consilium.europa.eu/uedocs/cms_data/docs/pressdata/en/lsa/131126.pdf.
23. Holden MTG, Hsu L-Y, Kurt K et al. A genomic portrait of the emergence, evolution and global spread of a methicillin resistant Staphylococcus aureus pandemic. Genome Res 2013; 23: 653-64.
24. Pluss-Suard C, Pannatier A, Kronenberg A et al. Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe. J Hosp Infect 2011; 79: 166-71.
25. Eurostat Healthcare Statistics. Hospital Beds Per 100000 Inhabitants. 2014. http://epp.eurostat.ec.europa.eu/tgm/table.do?tab=table&init=1&language=en&pcode=tps00046&plugin=1.
26. Kwint HM, van der Linden PD, Roukens MMB et al. on behalf of SWAB's Working Group on Surveillance of Antimicrobial Use. Intensification of antibiotic use within acute care hospitals in the Netherlands. J Antimicrob Chemother 2012; 67: 2283-8.
27. Polk RE, Hohmann SF, Medvedev S et al. Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis 2011; 53: 1100-10.
28. Transatlantic Task Force on Antimicrobial Resistance (TATFAR). 2014. http://www.cdc.gov/drugresistance/tatfar/index.html.
29. Sutton M, Nikolova S, Boaden R et al. Reduced mortality with hospital pay for performance in England. N Engl J Med 2012; 367: 1821-8.
30. The Scottish Government. Antimicrobial Prescribing Policy and Practice in Scotland: Recommendations for Good Antimicrobial Practice in Acute Hospitals. 2005. http://www.scotland.gov.uk/Publications/2005/09/02132609/26099.
31. Department of Health. The Health Act 2006: Code of Practice for the Prevention and Control of Healthcare Associated Infections. 277472. London: Crown, 2006; 41.
32. Department of Health. Essential Steps to Safe, Clean Care: Reducing Healthcare-Associated Infections. The Delivery Programme to Reduce Healthcare Associated Infections (HCAI) Including MRSA. London: Crown, 2006. http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4136212.
33. Acute Hospital Portfolio Topic Lead; Healthcare Commission. The Best Medicine: The Management of Medicines in Acute and Specialist Trusts. London: Commission for Healthcare Audit and Inspection, 2007.
34. Department of Health. Saving Lives: Reducing Infection, Delivering Clean and Safe Care. London: Crown, 2007. http://webarchive.nationalarchives. gov.uk/20130107105354/http://dh.gov.uk/en/publicationsandstatistics/publications/publicationspolicyandguidance/dh_078134.
35. Dellit TH, Owens RC, McGowan JE et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
36. Appendix 2 Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Antimicrobial Framework. J Antimicrob Chemother 2007; 60 Suppl 1: i87-90.
37. Department of Health. Clean, Safe Care: Reducing Infections and Saving Lives. London: Crown, 2008; 40. http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_081719.pdf.
38. Darzi A. High Quality Care For All: NHS Next Stage Review Final Report. Department of Health. London: Crown, 2008; 92. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/228836/7432.pdf.
39. Department of Health. The Health and Social Care Act 2008. London: Department of Health, 2010. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216227/dh_123923.pdf.
40. Department of Health. UK Five Year Antimicrobial Resistance Strategy 2013 to 2018. London: Department of Health, 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf.